GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

Yes, weight-loss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s Dr Sarah Jarvis reports ...

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

Employment Insurance (EI) benefits information, how to apply and how to submit a report. If you are self-employed, get information about the EI special benefits program, the agreement you will need to ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

They also have benefits for heart, immune, and gut health. This dark red fruit, found in wet habitats in parts of the United States, Canada, Chile, and Europe, is known for its tart flavor.

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

Once opened, compounded semaglutide typically lasts 28 days ... Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.